WHO ICTRP trial
Clinical Pathways for Acute Coronary Syndromes in China - phase 2…
ACTRN12609000491268 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12609000491268 |
|---|---|
| Public title | Clinical Pathways for Acute Coronary Syndromes in China - phase 2: implementation and evaluation |
| Scientific title | In patients with acute coronary syndromes admitted to urban hospitals in China, are clinical pathways effective for improving the quality of care. |
| Primary sponsor | Sanofi-Aventis (China) |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | China |
| Conditions | Acute Coronary Syndromes; Acute Coronary Syndromes;Cardiovascular - Coronary heart disease |
| Interventions | Clinical pathways in this study are standardized algorithms for the treatment of acute coronary syndromes that aim to optimize and streamline patient care. They are established according to American Heart Association (AHA) and American… |
| Registration date | Jun 19, 2009 |
| Target size | 15000 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: